Denái R. Milton, MS
- 2Articles
- 5.6KReads
- 2001–2005Active
- 7Collaborators
About
Denái R. Milton, MS, has contributed to research on neurodevelopmental and neurological disorders, focusing on the treatment of attention-deficit/hyperactivity disorder and schizophrenia. Publications include studies on the safety and efficacy of atomoxetine in adults with ADHD and the use of olanzapine for behavioral agitation and psychotic symptoms in schizophrenia. Milton's work has appeared in Psychiatrist.com between 2001 and 2005.
Publications
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
